Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.
Botulinum toxin type A treatment is the foundation of minimally invasive aesthetic facial procedures. Clinicians and their patients recognize the important role, both negative and positive, that facial expression, particularly the glabellar frown lines, plays in self-perception, emotional well-being, and perception by others. This article provides up-to-date information on fundamental properties and mechanisms of action of the major approved formulations of botulinum toxin type A, summarizes recent changes in naming conventions (nonproprietary names) mandated by the United States Food and Drug Administration, and describes the reasons for these changes. The request for these changes provides recognition that formulations of botulinum toxins (eg, onabotulinumtoxinA and abobotulinumtoxinA) are not interchangeable and that dosing recommendations cannot be based on any one single conversion ratio. The extensive safety, tolerability, and efficacy data are summarized in detail, including the patient-reported outcomes that contribute to overall patient satisfaction and probability treatment continuation. Based on this in-depth review, the authors conclude that botulinum toxin type A treatment remains a cornerstone of facial aesthetic treatments, and clinicians must realize that techniques and dosing from one formulation cannot be applied to others, that each patient should undergo a full aesthetic evaluation, and that products and procedures must be selected in the context of individual needs and goals.
De Boulle
Koenraad
K
Aalst Dermatology Clinic, Aalst, Belgium. koendeboulie@telenet.be
Fagien
Steven
S
Sommer
Boris
B
Glogau
Richard
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003357:Cosmetic Techniques; D005145:Face / Q000502:physiology*; D005260:Female; D006388:Hemagglutinins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017060:Patient Satisfaction; D015595:Skin Aging / Q000187:drug effects*; D014481:United States; D055815:Young Adult
D006388:Hemagglutinins; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
Skin Therapy Lett. 2008 Jul-Aug;13(6):1-4
18806905
J Am Acad Dermatol. 2009 Dec;61(6):961-70.e1-11
19744746
Plast Reconstr Surg. 2008 May;121(5 Suppl):5S-30S
18449026
Curr Med Chem. 2004 Dec;11(23):3085-92
15579002
Plast Reconstr Surg. 2007 Oct;120(5):1386-1393
17898617
Int Ophthalmol Clin. 2005 Summer;45(3):25-37
15970764
Am J Clin Dermatol. 2010;11(3):183-99
20369902
Dermatol Surg. 2008 Aug;34(8):1062-9
18462423
J Am Acad Dermatol. 2006 Dec;55(6):975-80
17097394
Dermatol Surg. 2003 May;29(5):456-60
12752511
Arch Dermatol. 2006 Mar;142(3):320-6
16549707
Plast Surg Nurs. 2005 Jan-Mar;25(1):5-20
15785350
J Am Acad Dermatol. 2004 Aug;51(2):223-33
15280841
Dermatol Surg. 2006 May;32(5):645-9; discussion 649-50
16706759
Aesthet Surg J. 2005 Jul-Aug;25(4):365-75
19338833
Dermatol Surg. 2008 Jan;34(1):52-9
18053050
J Am Acad Dermatol. 2009 Sep;61(3):421-5
19577326
Dermatol Surg. 2007 Jan;33(1 Spec No.):S51-9
17241415
Toxicon. 2009 Oct;54(5):697-701
19292989
Am Psychol. 1993 Apr;48(4):384-92
8512154
Ann Plast Surg. 2004 May;52(5):442-7; discussion 447
15096921
Plast Reconstr Surg. 2008 Jun;121(6):413e-422e
18520868
J Cosmet Laser Ther. 2007;9 Suppl 1:17-22
17885882
J Cosmet Laser Ther. 2004 Nov;6(3):145-8
15545098
Dermatol Surg. 2003 May;29(5):519-22; discussion 522
12752521
Dermatol Surg. 2003 May;29(5):501-7; discussion 507
12752518
Arch Facial Plast Surg. 2001 Jul-Sep;3(3):165-9
11497500
Dermatol Surg. 2007 Jan;33(1 Spec No.):S10-7
17241408
Dermatol Surg. 2003 May;29(5):508-15
12752519
Int J Dermatol. 2009 Jul;48(7):768-76
19490208
Arch Facial Plast Surg. 2009 Mar-Apr;11(2):77-83
19289677
Arch Otolaryngol Head Neck Surg. 1997 Apr;123(4):389-92
9109785
J Neural Transm (Vienna). 2005 Jul;112(7):905-13
15526142
Eur J Neurol. 2006 Dec;13 Suppl 4:1-9
17112344
Biol Psychol. 1986 Oct;23(2):153-61
3790652
J Cosmet Laser Ther. 2008 Jun;10(2):87-92
18569261
Dermatol Surg. 1999 Apr;25(4):259-61
10417577
Plast Reconstr Surg. 2004 Nov;114(6 Suppl):1S-22S
15507786
Dermatol Nurs. 1997 Oct;9(5):329-33, 365
9392763
Dermatol Surg. 2003 May;29(5):496-500; discussion 500
12752517
Br J Clin Psychol. 1998 Sep;37(3):341-53
9784888
Lancet. 1990 Aug 4;336(8710):322-3
1974017
Dermatol Surg. 2006 Feb;32(2):184-97
16442037
Dermatol Surg. 2009 Dec;35(12):1893-901
19549186
Acta Dermatovenerol Croat. 2009;17(1):48-53
19386215
Aesthetic Plast Surg. 1999 Nov-Dec;23(6):416-23
10629298
Dermatol Surg. 2009 Sep;35(9):1324-33
19496792
Dermatol Surg. 2007 Jan;33(1 Spec No.):S2-9
17241410
J Dermatol Surg Oncol. 1992 Jan;18(1):17-21
1740562
Dermatol Surg. 2005 Apr;31(4):414-22; discussion 422
15871316
Dermatol Surg. 2007 Jan;33(1 Spec No.):S97-104
17241422
Expert Opin Pharmacother. 2007 Jun;8(8):1059-72
17516871
J Cosmet Dermatol. 2009 Mar;8(1):24-6
19250162
Dermatol Surg. 2007 Jan;33(1 Spec No.):S76-80
17241418
Aesthetic Plast Surg. 2008 Sep;32(5):724-30
18663516
Dermatol Surg. 2007 Jan;33(1 Spec No.):S18-25
17241409
Otolaryngol Head Neck Surg. 2002 May;126(5):459-67
12075218
J Pers Soc Psychol. 1988 May;54(5):768-77
3379579
Facial Plast Surg Clin North Am. 2007 Feb;15(1):51-4, vi
17317555
J Cosmet Dermatol. 2008 Mar;7(1):50-4
18254812
Plast Reconstr Surg. 2008 Dec;122(6):1915-1925
19050545
Dermatol Surg. 2005 Oct;31(10):1297-303
16188182
Plast Reconstr Surg. 2009 Nov;124(5):1619-1629
19584772
Eur J Neurol. 2001 Nov;8 Suppl 5:21-9
11851731
Dermatol Surg. 2009 Mar;35(3):429-35; discussion 435-6
19250310
J Am Acad Dermatol. 2003 Aug;49(2):213-6
12894067
Dermatol Surg. 2003 Aug;29(8):802-9
12859378
Eur J Neurol. 2006 Feb;13 Suppl 1:2-10
16417591
Clin Neuropharmacol. 2009 Jan-Feb;32(1):28-31
18978494
Dermatol Surg. 2003 May;29(5):444-9; discussion 449
12752509
Dermatol Surg. 2004 Mar;30(3):355-66; discussion 366
15008861